152 clinics and counting: ED shock wave therapy scales well ahead of its evidence

A treatment for erectile dysfunction that the U.S. Food and Drug Administration has not approved is being sold, session by session, in American men's health clinics, and leading physician groups decline to support it because evidence of long-term benefit is spotty ^[1][2]. The gap between commercial scale and evidentiary support is the story here: a course runs six to 12 visits that may cost several hundred dollars each, paid out of pocket ^[6].

The demand is real. An analysis of 2021 survey data found that 24.2 percent of U.S. men who responded had symptoms consistent with ED, rising to 52.2 percent among those 75 and older ^[7], roughly 2.2 times the overall rate ^[21]. Shock wave therapy targets one slice of that: damaged blood flow. James Weinberger, a urological surgeon in Beverly Hills, describes erectile tissue as a sponge that in men with diabetes, high blood pressure or high cholesterol becomes scarred and less able to hold blood under pressure ^[3]. ED can also stem from medications, anxiety and other nonvascular causes, which this device does not address ^[4].

On the supply side, Weinberger and colleagues reported in 2022 that at least 152 clinics across eight of the largest U.S. metro areas offered the therapy, and he says that figure "certainly undercounts what exists today" ^[8][9]. Men's health providers routinely bundle it with testosterone supplementation and medication ^[10].

The physics is borrowed. High-energy shock waves have shattered kidney stones for decades ^[11]; the ED version uses low-intensity waves delivered by a wandlike device to several areas of the penis for 15 to 20 minutes, with a snapping sound and, in principle, no pain ^[12]. Taylor Kohn, a urologist at Baylor College of Medicine, says the energy creates microscopic mechanical stresses at the cellular level, with the theoretical goal of restoring tissue rather than compensating for it the way a pill does ^[13].

The evidence has not kept pace with the storefronts. The founding result is a 2010 trial in 20 middle-aged men, half of whom, six months out, improved enough for penetrative sex without Viagra-type drugs ^[14]: ten men ^[22]. Cochrane's reviewers analyzed 21 studies and concluded the technique might produce a small effect on erectile function in the first few months and could have some longer-term benefit, but variability across the studies shook their confidence ^[15]. A 2026 report in Sexual Medicine Reviews found the trials small and inconsistent in session count, making them hard to compare, while noting that none reported evidence of harm ^[16]. Kohn says most trial side effects are skin reactions to the coupling gel ^[17].

Who holds the wand is the sharper operational point. Among providers at those 152 clinics, only 25 percent were urologists ^[18]; three in four were not ^[23], a group that included primary care physicians, plastic surgeons, dermatologists and chiropractors ^[18]. Weinberger argues that matters because treatment should include conversations about hormones and medications, and stand-alone ED clinics may not offer comprehensive care ^[19]. Kohn restricts the therapy to men who still respond to oral drugs, saying that for men with no response or no erections at all, "it's kind of a waste of time" ^[20].

Watch whether the next round of trials standardizes session counts, since that inconsistency is what blunted both reviews ^[15][16]. Watch for any FDA action ^[1] and for guideline updates from the American Urological Association and the Sexual Medicine Society of North America, which Science News cites on the evidence question ^[5]. Until then, with no harm signal in the literature, the exposure a patient carries is mostly financial: at $300 a session, a full course is $1,800 to $3,600 ^[24].